Bioaegis Therapeutics Inc.

Morristown, NJ

UEI
G2AZAC2PG7X3
CAGE
6QA91
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
6 E Cove Ln, Morristown, NJ 07960, USA
Founded
2011
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 $0
FY2023 $20,000,000

Contract awards

Quick answers

Is Bioaegis Therapeutics Inc. registered in SAM.gov?

Yes. Bioaegis Therapeutics Inc.'s SAM.gov registration is active through October 31, 2027.

What is Bioaegis Therapeutics Inc.'s CAGE code?

Bioaegis Therapeutics Inc.'s CAGE code is 6QA91, and its Unique Entity ID (UEI) is G2AZAC2PG7X3.

How much has Bioaegis Therapeutics Inc. received in federal contracts?

Federal contracts obligated $20,000,000 to Bioaegis Therapeutics Inc. in fiscal years 2023 through 2027.

What is Bioaegis Therapeutics Inc.'s most recent federal award?

Bioaegis Therapeutics Inc.'s most recent federal contract award is Bioaegis: plasma gelsolin (PGSN), an abundant, circulating protein modulates inflammation while also enhancing host… (75A50123C00067), from Office of the Assistant Secretary for Preparedness and Response, on September 21, 2023.

On GovTribe

See Bioaegis Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe